Lynx1 Capital Management LP
23 holdingsFiling period: 2026-06-30Current AUM: $419.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics Inc | 8.96M | $163.2M | $130.3M | 31.07% | -- | 2026-06-30 |
| 2 | STOK | Stoke Therapeutics Inc | 4.04M | $132.1M | $102.8M | 24.51% | -725,269 | 2026-06-30 |
| 3 | AGIO | Agios Pharmaceuticals Inc | 3.41M | $126.5M | $125.6M | 29.95% | +797.4K | 2026-06-30 |
| 4 | CCCC | C4 Therapeutics Inc | 7.33M | $34.2M | $21.8M | 5.21% | +327.8K | 2026-06-30 |
| 5 | KRRO | Korro Bio Inc | 1.54M | $20.3M | $18.5M | 4.41% | -- | 2026-06-30 |
| 6 | TCRX | Tscan Therapeutics Inc | 8.02M | $7.9M | $1.5M | 0.36% | -- | 2026-06-30 |
| 7 | DTIL | Precision Biosciences Inc | 950.5K | $7.5M | $6.1M | 1.45% | -34,647 | 2026-06-30 |
| 8 | NEUP | Neuphoria Therapeutics Inc | 875.3K | $3.8M | $3.0M | 0.71% | -- | 2026-06-30 |
| 9 | PASG | Passage Bio Inc | 673.8K | $3.3M | $2.3M | 0.54% | +50.1K | 2026-06-30 |
| 10 | CGON | CG Oncology Inc | 31.4K | $2.2M | $1.9M | 0.46% | -200 | 2026-06-30 |
| 11 | PLRX | Pliant Therapeutics Inc | 1.80M | $2.0M | $1.5M | 0.36% | -- | 2026-06-30 |
| 12 | TRDA | Entrada Therapeutics Inc | 178.6K | $1.3M | $848K | 0.20% | -33,083 | 2026-06-30 |
| 13 | VYNE | Vyne Therapeutics Inc | 1.63M | $1.1M | $1.1M | 0.25% | -- | 2026-06-30 |
| 14 | TRAW | Traws Pharma Inc | 559.5K | $471K | $191K | 0.05% | +544.4K | 2026-06-30 |
| 15 | FHTX | Foghorn Therapeutics Inc | 61.6K | $300K | $126K | 0.03% | -- | 2026-06-30 |
| 16 | DNLI | Denali Therapeutics Inc | 11.7K | $299K | $217K | 0.05% | -1,868,645 | 2026-06-30 |
| 17 | XNCR | Xencor Inc | 18.2K | $292K | $529K | 0.13% | -518,204 | 2026-06-30 |
| 18 | HOWL | Werewolf Therapeutics Inc | 657.8K | $236K | $643K | 0.15% | -- | 2026-06-30 |
| 19 | AVTX | Avalo Therapeutics Inc | 10.1K | $186K | $68K | 0.02% | -- | 2026-06-30 |
| 20 | BOLT | Bolt Biotherapeutics Inc | 30.8K | $118K | $202K | 0.05% | -- | 2026-06-30 |
| 21 | NUVB | Nuvation Bio Inc | 16.0K | $91K | $72K | 0.02% | -- | 2026-06-30 |
| 22 | EPRX | Eupraxia Pharmaceuticals Inc | 10.0K | $66K | $68K | 0.02% | -- | 2026-06-30 |
| 23 | IKT | Inhibikase Therapeutics Inc | 20.0K | $40K | $30K | 0.01% | -- | 2026-06-30 |
← Scroll →